sumatriptan has been researched along with cyclic gmp in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maura, G; Raiteri, M | 1 |
| Baird, M; Clayton, RA; Johnston, ED; MacLean, MR; Sheridan, S; Sweeney, G; Templeton, A | 1 |
| Chalimoniuk, M; Stepien, A | 1 |
| Chalimoniuk, M; Stepień, A; Strosznajder, J | 1 |
| Hirst, WD; Parsons, AA; Read, SJ; Upton, N | 1 |
| Carøe Nordgaard, J; Gammeltoft, S; Kruse, LS; Kruuse, CR | 1 |
6 other study(ies) available for sumatriptan and cyclic gmp
| Article | Year |
|---|---|
Serotonin 5-HT1D and 5-HT1A receptors respectively mediate inhibition of glutamate release and inhibition of cyclic GMP production in rat cerebellum in vitro.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Afferent Pathways; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cerebellum; Cyclic GMP; Glutamic Acid; Male; N-Methylaspartate; Oxadiazoles; Piperazines; Potassium; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1D; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Agents; Signal Transduction; Sumatriptan; Synapses; Synaptic Transmission | 1996 |
Contractile responses to sumatriptan in isolated bovine pulmonary artery rings: relationship to tone and cyclic nucleotide levels.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cattle; Cyclic AMP; Cyclic GMP; In Vitro Techniques; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Serotonin Receptor Agonists; Sumatriptan; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 1995 |
Level of nitric oxide-dependent cGMP in patients with migraine.
Topics: Adult; Cyclic GMP; Female; Humans; Male; Middle Aged; Migraine Disorders; Nitric Oxide; Serotonin Receptor Agonists; Sumatriptan | 1998 |
Serotonin 5HT1B/1D receptor agonists abolish NMDA receptor-evoked enhancement of nitric oxide synthase activity and cGMP concentration in brain cortex slices.
Topics: Animals; Cerebral Cortex; Cyclic GMP; Excitatory Amino Acid Agonists; Male; N-Methylaspartate; Nitric Oxide Synthase; Oxazoles; Oxazolidinones; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Serotonin Receptor Agonists; Sumatriptan; Tryptamines | 1999 |
Cortical spreading depression produces increased cGMP levels in cortex and brain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan.
Topics: Analgesics; Animals; Benzamides; Benzopyrans; Brain Stem; Cerebral Cortex; Cortical Spreading Depression; Cyclic GMP; Male; Migraine Disorders; Nitric Oxide; Nitric Oxide Synthase; Potassium Chloride; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sumatriptan; Vasoconstrictor Agents | 2001 |
Role of Ser102 and Ser104 as regulators of cGMP hydrolysis by PDE5A.
Topics: Amino Acid Substitution; Calcitonin Gene-Related Peptide; Catalytic Domain; Cell Line; Cilostazol; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Humans; In Vitro Techniques; Models, Molecular; Nitroglycerin; Phosphodiesterase Inhibitors; Piperazines; Purines; Serine; Sildenafil Citrate; Sulfonamides; Sumatriptan; Tetrazoles | 2014 |